Statements and Testimony

The ASM Office of Public Affairs has completed a summary of the Administration's FY 2018 budget proposal with programs and agencies of importance to the microbial sciences.
The ASM signed onto a coalition letter to Congressional leadership urging support for scientific research as they begin work on the FY 2018 appropriations.
ASM Letter regarding the nomination of the Undersecretary for Research, Education and Economics at the U.S. Department of Agriculture
The ASM has released a statement on the release of the Administration’s FY 2018 Budget urging Congress to reject the Administration’s proposed severe cuts to science and public health programs.  
The ASM sent a letter to all members of Congress thanking them for their efforts to increase funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the US Department of Agriculture and the Department of Energy Office of Science and the Food and Drug Administration…
The ASM signed onto a letter sent to House and Senate appropriations committee leaders calling on Congress to increase the fiscal 2018 302(b) subcommittee allocations for Labor-HHS.
ASM joined the Infectious Diseases Society of America (IDSA) and the Pan American Society for Clinical Virology (PASCV) in drafting comments for the draft Diagnostic Accuracy and Innovation Act (DAIA) legislation.  The DAIA builds upon previous efforts to establish a new framework for the regulation of both in vitro diagnostic…
The ASM submitted funding recommendations for the Department of Defense for FY 2018 to Congress.
The ASM submitted funding recommendations for the Department of Energy Office of Science for FY 2018 to Congress.
ASM activities on Capitol Hill in support of agricultural research.
The ASM signed onto a letter to Congress urging completion the FY 2017 appropriations process with robust investments in scientific research.
The ASM submitted funding recommendations for the US Department of Agriculture for FY 2018 to Congress.
The ASM submitted funding recommendations for the National Science Foundation for FY 2018 to Congress.
The ASM submitted funding recommendations for the Food and Drug Administration for FY 2018 to Congress.
The ASM sent a statement to members of Congress urging support for funding growth for biomedical research, science and public health programs. 
ASM and the Pan American Society of Clinical Virology (PASCV) drafted a letter expressing concerns about the turnaround time for results in the Zika plaque reduction neutralizing test (PRNT) currently available and suggested some solutions.   
The ASM signed onto a letter to Mr. António Guterres, United Nations Secretary-General and Dr. Margaret Chan, World Health Organization Director-General regarding the progress since the political declaration of the high level meeting on antimicrobial resistance (AMR) in the United Nations (UN) General Assembly in September 2016.
The ASM signed on to a letter to President Trump regarding the essential role of the federal public health and biomedical research workforce as long-term policy regarding federal hiring is considered.
The ASM submitted funding recommendations for the National Institutes of Health for FY 2018 to Congress. 
Page 1 of 2

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

113

Joomla! Debug Console

Session

Profile Information

Memory Usage

Database Queries